Novozymes A/S
CPSE:NSIS B
kr 380,20
+ kr5,50 (1,47%)
380,20 kr
+kr5,50 (1,47%)
End-of-day quote: 03/27/2026

Novozymes A/S Stock Value

Currently, analysts rate CPSE:NSIS B as Outperform.
Outperform
Outperform

Novozymes A/S Company Info

EPS Growth 5Y
3,22%
Market Cap
kr177,14 B
Long-Term Debt
kr11,41 B
Quarterly earnings
05/08/2026 (E)
Dividend
kr6,58
Dividend Yield
1,73%
Founded
1925
Industry
Country
Website
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

kr460,00
20.99%
20.99
Last Update: 03/29/2026
Analysts: 17

Highest Price Target kr560,00

Average Price Target kr460,00

Lowest Price Target kr362,00

In the last five quarters, Novozymes A/S’s Price Target has fallen from kr514,22 to kr486,25 - a -5,44% decrease. Twelve analysts predict that Novozymes A/S’s share price will increase in the coming year, reaching kr460,00. This would represent an increase of 20,99%.

Top growth stocks in the health care sector (5Y.)

What does Novozymes A/S do?

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics. The company focuses on sustainable solutions that enhance the efficiency of various processes across multiple industries, including agriculture, food and beverages, bioenergy, and household care. Business Segments The company operates through several key business segments, each tailored to address specific industry needs. These segments include Agriculture, Food and Beverages, Bioenergy, and Household Care. I...

Novozymes A/S Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**Industry revenues:** - Bioenergy: approx. 30% - Food and beverages: approx. 25% - Agriculture and nutrition: approx. 20% - Household care: approx. 15% - Other industries: approx. 10% **TOP 3 markets:** - USA: approx. 35% - Europe: approx. 30% - Asia-Pacific: approx. 20% Novozymes A/S generates i...
At which locations are the company’s products manufactured?
**Production sites of Novozymes A/S:** 1. **Denmark** 2. **USA** 3. **Brazil** 4. **China** 5. **India** Novozymes A/S produces its products at several international locations to efficiently meet global demand. The main production sites are located in Denmark, where the company is headquartered. I...
What strategy does Novozymes A/S pursue for future growth?
**Revenue Growth:** Estimated 5-7% annually (2025) **R&D Investments:** Over 13% of revenue (2024) Novozymes A/S pursues a growth strategy that is strongly focused on innovation and sustainability. The company continuously invests a significant portion of its revenue in research and development...
Which raw materials are imported and from which countries?
**Main raw materials:** Enzymes, microorganisms, biopolymers **Key importing countries:** USA, China, Brazil Novozymes A/S is a leading company in biotechnology specializing in the production of enzymes and microorganisms. The main raw materials that the company imports include enzymes, microorgan...
How strong is the company’s competitive advantage?
**Market Share:** Approx. 48% in the industrial enzymes sector (2024) **Research & Development:** 13% of revenue invested (2024) **Patents:** Over 7,000 active patents worldwide (2024) Novozymes A/S possesses a significant competitive advantage, primarily based on its leading position in the...
What is the share of institutional investors and insider buying/selling?
**Institutional investor share:** approx. 60% (estimated, based on previous trends) **Insider purchases/sales:** No significant transactions in the last year (estimated) The institutional investor share at Novozymes A/S traditionally stands at around 60%, indicating the trust of large investors in...
What percentage market share does Novozymes A/S have?
**Market share of Novozymes A/S:** 48% (2025, estimated) **Main competitors and their market shares:** 1. **Novozymes A/S:** 48% 2. **DuPont (Danisco):** 20% 3. **DSM:** 12% 4. **BASF:** 8% 5. **Chr. Hansen:** 6% 6. **AB Enzymes:** 3% 7. **Kerry Group:** 2% 8. **Advanced Enzyme Technologies:** 1%...
Is Novozymes A/S stock currently a good investment?
**Revenue growth:** 5.8% (2024) **EBITDA margin:** 28.4% (2024) **Research & Development (R&D) expenses:** 13% of revenue (2024) Novozymes A/S is a leading company in the field of biotechnology, specializing in the development of enzymes and microorganisms. In 2024, the company experienced...
Does Novozymes A/S pay a dividend – and how reliable is the payout?
**Dividend yield:** 1.8% (2024) **Dividend growth:** 5% (annually, average over the last 5 years) Novozymes A/S has consistently paid dividends in recent years, indicating a reliable dividend policy. The dividend yield was recently at 1.8%, which can be considered moderate compared to other compani...
×